Article Details
Retrieved on: 2024-02-07 18:49:35
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses BioLargo Inc.'s revenue surge due to its Cleantech product, Pooph, and mentions analyst Richard Ryan's optimistic securities research, within the framework of U.S. corporate law and SEC filings for investment banking consideration.
Article found on: www.streetwisereports.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here